These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 22230390)

  • 1. Bridging the gap between the clinician and the patient with cryopyrin-associated periodic syndromes.
    Cantarini L; Lucherini OM; Frediani B; Brizi MG; Bartolomei B; Cimaz R; Galeazzi M; Rigante D
    Int J Immunopathol Pharmacol; 2011; 24(4):827-36. PubMed ID: 22230390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cryopyrin-associated periodic syndromes].
    Quartier P; Rodrigues F; Georgin-Lavialle S
    Rev Med Interne; 2018 Apr; 39(4):287-296. PubMed ID: 29111302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of cryopyrin-associated periodic syndrome: challenges, recommendations and emerging concepts.
    Sarrabay G; Grandemange S; Touitou I
    Expert Rev Clin Immunol; 2015; 11(7):827-35. PubMed ID: 25979514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Muckle-Wells syndrome caused by a new cryopyrin mutation: effective treatment with interleukin-1 antagonist].
    Rameev VV; Kozlovskaia LV; Bogdanova MV
    Ter Arkh; 2012; 84(6):53-9. PubMed ID: 22997920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muckle-Wells cryopyrinopathy: complex phenotyping and response to therapy in a new multiplex kindred.
    Headley AP; Cordingley F; Hawkins PN; Riminton DS
    Inflammation; 2014 Apr; 37(2):396-401. PubMed ID: 24150829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome.
    Koné-Paut I; Galeotti C
    Expert Rev Clin Immunol; 2015; 11(10):1083-92. PubMed ID: 26312542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathophysiological mechanisms underlying cryopyrin-associated periodic syndromes: genetic and molecular basis and the inflammasome].
    Aróstegui JI
    Med Clin (Barc); 2011 Jan; 136 Suppl 1():22-8. PubMed ID: 21596183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Mutation in the Pyrin Domain of the NOD-like Receptor Family Pyrin Domain Containing Protein 3 in Muckle-Wells Syndrome.
    Hu J; Zhu Y; Zhang JZ; Zhang RG; Li HM
    Chin Med J (Engl); 2017 Mar; 130(5):586-593. PubMed ID: 28229991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canakinumab for the treatment of cryopyrin-associated periodic syndromes.
    Walsh GM
    Drugs Today (Barc); 2009 Oct; 45(10):731-5. PubMed ID: 20069137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonclassic neurologic features in cryopyrin-associated periodic syndromes.
    Ting TV; Scalzi LV; Hashkes PJ
    Pediatr Neurol; 2007 May; 36(5):338-41. PubMed ID: 17509468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed reactivation of chronic infantile neurologic, cutaneous, articular syndrome (CINCA) in a patient with somatic mosaicism of CIAS1/NLRP3 gene after withdrawal of anti-IL-1 beta therapy.
    Paloni G; Pastore S; Tommasini A; Lepore L; Taddio A
    Clin Exp Rheumatol; 2015; 33(5):766. PubMed ID: 26316056
    [No Abstract]   [Full Text] [Related]  

  • 12. Muckle-Wells Syndrome: A Case Report with an NLRP3 T348M Mutation.
    Naz Villalba E; Gomez de la Fuente E; Caro Gutierrez D; Pinedo Moraleda F; Yanguela Rodilla J; Mazagatos Angulo D; López Estebaranz JL
    Pediatr Dermatol; 2016 Sep; 33(5):e311-4. PubMed ID: 27435956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Update in interleukin-1 inhibition].
    de Boysson H
    Rev Med Interne; 2012 Apr; 33(4):235-7. PubMed ID: 22360831
    [No Abstract]   [Full Text] [Related]  

  • 14. [Genetics of cryopyrin-associated periodic syndrome].
    Kümmerle-Deschner JB; Lohse P
    Z Rheumatol; 2017 May; 76(4):313-321. PubMed ID: 28197772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation in the CIAS1/NLRP3 gene associated with an unexpected phenotype of cryopyrin-associated periodic syndromes.
    Insalaco A; Prencipe G; Buonuomo PS; Ceccherini I; Bracaglia C; Pardeo M; Nicolai R; De Benedetti F
    Clin Exp Rheumatol; 2014; 32(1):123-5. PubMed ID: 24144430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurologic manifestations of the cryopyrin-associated periodic syndrome.
    Kitley JL; Lachmann HJ; Pinto A; Ginsberg L
    Neurology; 2010 Apr; 74(16):1267-70. PubMed ID: 20404307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal treatment of CINCA syndrome.
    Paccaud Y; Berthet G; Von Scheven-Gête A; Vaudaux B; Mivelaz Y; Hofer M; Roth-Kleiner M
    Pediatr Rheumatol Online J; 2014; 12():52. PubMed ID: 25584041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic cutaneous lesions in a 73-year-old patient].
    Abbara S; Bachmeyer C; Stankovic Stojanovic K; Amselem S; Grateau G; Georgin-Lavialle S; Couturier B; Cogan E
    Rev Med Interne; 2015 Sep; 36(9):631-3. PubMed ID: 26051190
    [No Abstract]   [Full Text] [Related]  

  • 19. Cryopyrin-associated periodic syndrome: a case report and review of the Japanese literature.
    Aoyama K; Amano H; Takaoka Y; Nishikomori R; Ishikawa O
    Acta Derm Venereol; 2012 Jul; 92(4):395-8. PubMed ID: 22377911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cryopyrin-associated periodic syndromes (CAPS)].
    Yagüe J
    Med Clin (Barc); 2011 Jan; 136 Suppl 1():1-2. PubMed ID: 21596179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.